Search
for
Sort by
Research 30 of 110
- Clinical outcomes and considerations in outpatient with COVID‐19 receiving remdesivir therapy
- Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- A protocol for assessment of interventions using a computational phenotype for Long COVID
- Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Reporting on Adverse Clinical Events
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model
- The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- An update of anti-viral treatment of COVID-19
- Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Redefining Drug Discovery: A Review of Drug Repurposing –Approaches, Benefits and Breakthroughs
- Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
- Clinical course of alopecia after COVID-19
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner